{
    "id": 27804,
    "cites": 77,
    "cited_by": 0,
    "reference": [
        "Abouk, Rahi, Ali Moghtaderi, Lorens A. Helmchen, and Jesse Pines. Did the ACA Medicaid Expansions Fuel the Opioid Epidemic? Available at SSRN 3368434 (2019).",
        "Acemoglu, Daron, David Autor, David Dorn, Gordon H. Hanson, and Brendan Price. Import competition and the great US employment sag of the 2000s. Journal of Labor Economics 34, no. S1 (2016): S141-S198.",
        "Ahrens, Achim, Christian B. Hansen, and Mark Schaffer. LASSOPACK: Stata module for lasso, square-root lasso, elastic net, ridge, adaptive lasso estimation and cross-validation. (2019).",
        "Ahrens, Achim, Christian B. Hansen, and Mark E. Schaffer. lassopack: Model selection and prediction with regularized regression in Stata. The Stata Journal 20, no. 1 (2020): 176-235.",
        "Aliprantis, Dionissi, Kyle Fee, and Mark E. Schweitzer. Opioids and the Labor Market. (2019). https://www.clevelandfed.org/en/newsroom-and-events/publications/working-papers/2019working -papers/wp-1807r-opioids-and-labor-market.aspx Alpert, Abby E., William N. Evans, Ethan MJ Lieber, and David Powell. Origins of the Opioid Crisis and Its Enduring Impacts. No. w26500. National Bureau of Economic Research, 2019.",
        "Alpert, Abby, David Powell, and Rosalie Liccardo Pacula. Supply-side drug policy in the presence of substitutes: Evidence from the introduction of abuse-deterrent opioids. American Economic Journal: Economic Policy 10, no. 4 (2018): 1-35.",
        "Autor, David H., and Mark G. Duggan. The rise in the disability rolls and the decline in unemployment. The Quarterly Journal of Economics 118, no. 1 (2003): 157-206.",
        "Autor, David H., David Dorn, and Gordon H. Hanson. The China syndrome: Local labor market effects of import competition in the United States. American Economic Review 103, no. 6 (2013): 212168. Autor, David H., Nicole Maestas, Kathleen J. Mullen, and Alexander Strand. Does delay cause decay? The effect of administrative decision time on the labor force participation and earnings of disability applicants. No.",
        "w20840. National Bureau of Economic Research, 2015.",
        "Bartholow, Michael. Top 200 drugs of 2010. Pharmacy Times 77, no. 5 (2011): 52.",
        "Bartik, Timothy J. Who benefits from state and local economic development policies? W.E. Upjohn Institute for Employment Research (1991).",
        "Becker, William C., and David A. Fiellin. Abuse-deterrent opioid formulations\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dputting the potential benefits into perspective. New England Journal of Medicine 376, no. 22 (2017): 2103-2105.",
        "Beheshti, David. Adverse health effects of abuse\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u0090deterrent opioids: Evidence from the reformulation of OxyContin. Health Economics 28, no. 12 (2019): 1449-1461.",
        "Beheshti, David. The Impact of Opioids on the Labor Market: Evidence from Drug Rescheduling. Working Paper (2019).",
        "Belloni, Alexandre, and Victor Chernozhukov. Least squares after model selection in highdimensional sparse models. Bernoulli 19, no. 2 (2013): 521-547.",
        "Belloni, Alexandre, Victor Chernozhukov, and Lie Wang. Square-root lasso: pivotal recovery of sparse signals via conic programming. Biometrika 98, no. 4 (2011): 791-806.",
        "Belloni, Alexandre, Daniel Chen, Victor Chernozhukov, and Christian Hansen. Sparse models and methods for optimal instruments with an application to eminent domain. Econometrica 80, no. 6 (2012): 2369-2429.",
        "Bertrand, Marianne, Esther Duflo, and Sendhil Mullainathan. How much should we trust differences-in-differences estimates? The Quarterly Journal of Economics 119, no. 1 (2004): 249-275.",
        "Betz, Michael R., and Lauren E. Jones. Wage and employment growth in America\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2s drug epidemic: Is all growth created equal? American Journal of Agricultural Economics 100, no. 5 (2018): 1357-1374.",
        "Black, Dan, Kermit Daniel, and Seth Sanders. The impact of economic conditions on participation in disability programs: Evidence from the coal boom and bust. American Economic Review 92, no. 1 (2002): 27-50.",
        "Blanchard, Olivier and Lawrence F. Katz. Regional evolutions. Brookings Papers on Economic Activity, Economic Studies Program, The Brookings Institution 23, no. 1 (1992).",
        "Brucker, Debra. Estimating the prevalence of substance use, abuse, and dependence among Social Security Disability benefit recipients. Journal of Disability Policy Studies 18, no. 3 (2007): 148-159.",
        "B\u00c3\u0083\u00c2\u00bctikofer, Aline, and Meghan M. Skira. Missing Work Is a Pain The Effect of Cox-2 Inhibitors on Sickness Absence and Disability Pension Receipt. Journal of Human Resources 53, no. 1 (2018): 71122.",
        "Butler, Stephen F., Theresa A. Cassidy, Howard Chilcoat, Ryan A. Black, Craig Landau, Simon H. Budman, and Paul M. Coplan. Abuse rates and routes of administration of reformulated extendedrelease oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment. The Journal of Pain 14, no. 4 (2013): 351-358.",
        "Charles, Kerwin Kofi, Erik Hurst, and Mariel Schwartz. The transformation of manufacturing and the decline in US employment. NBER Macroeconomics Annual 33, no. 1 (2019): 307-372.",
        "Charles, Kerwin Kofi, Yiming Li, and Melvin Stephens Jr. Disability benefit take-up and local labor market conditions. Review of Economics and Statistics 100, no. 3 (2018): 416-423.",
        "Ciani, Emanuele, and Paul Fisher. Dif-in-dif estimators of multiplicative treatment effects. Journal of Econometric Methods 8, no. 1 (2018).",
        "Ciccarone, Daniel. Fentanyl in the US heroin supply: a rapidly changing risk environment. The International Journal on Drug Policy 46 (2017): 107-111.",
        "Cicero, Theodore J., and Matthew S. Ellis. Abuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: lessons learned from OxyContin. JAMA Psychiatry 72, no. 5 (2015): 424-430.",
        "Cicero, Theodore J., James A. Inciardi, and Alvaro Mu\u00c3\u0083\u00c2\u00b1oz. Trends in abuse of OxyContin and other opioid analgesics in the United States: 2002-2004. The Journal of Pain 6, no. 10 (2005): 662-672.",
        "Currie, Janet, Jonas Jin, and Molly Schnell. US Employment and Opioids: Is There a Connection? In Health and Labor Markets, pp. 253-280. Emerald Publishing Limited, 2019.",
        "Davis, Matthew A., Lewei A. Lin, Haiyin Liu, and Brian D. Sites. Prescription opioid use among adults with mental health disorders in the United States. The Journal of the American Board of Family Medicine 30, no. 4 (2017): 407-417.",
        "Deiana, Claudio, and Ludovica Giua. The US Opioid Epidemic: Prescription Opioids, Labour Market Conditions and Crime. Working Paper (2019).",
        "DeSimone, Jeff. Illegal drug use and employment. Journal of Labor Economics 20, no. 4 (2002): 952977.",
        "Evans, Mary F., Matthew Harris, and Lawrence Kessler. The Hazards of Unwinding the Prescription Opioid Epidemic: Implications for Child Abuse and Neglect. Available at SSRN 3582060 (2020).",
        "Evans, William N., Ethan MJ Lieber, and Patrick Power. How the reformulation of OxyContin ignited the heroin epidemic. Review of Economics and Statistics 101, no. 1 (2019): 1-15.",
        "Feingold, Daniel, Silviu Brill, Itay Goor-Aryeh, Yael Delayahu, and Shaul Lev-Ran. The association between severity of depression and prescription opioid misuse among chronic pain patients with and without anxiety: a cross-sectional study. Journal of Affective Disorders 235 (2018): 293-302.",
        "Finsterer, Josef, and Claudia St\u00c3\u0083\u00c2\u00b6llberger. Neurological Abnormalities in Opiate Addicts. In Neuropathology of Drug Addictions and Substance Misuse, pp. 947-955. Academic Press, 2016.",
        "Franco, Armando, Zachary Wagner, and Christopher M. Whaley. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Doped up or Dropped Out: The Effects of Opioid Use on Workplace Absences.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Working Paper (2019).",
        "French, Michael T., M. Christopher Roebuck, and Pierre Kebreau Alexandre. Illicit drug use, employment, and labor force participation. Southern Economic Journal (2001): 349-368.",
        "French, Eric, and Jae Song. The effect of disability insurance receipt on labor supply. American Economic Journal: Economic Policy 6, no. 2 (2014): 291-337.",
        "Garthwaite, Craig L. The economic benefits of pharmaceutical innovations: The case of Cox-2 inhibitors. American Economic Journal: Applied Economics 4, no. 3 (2012): 116-37.",
        "General Accounting Office (GAO). Prescription drugs OxyContin abuse and diversion and efforts to address the problem: report to Congressional requesters. DIANE Publishing, 2003.",
        "Ghimire, Keshar M., and Johanna Catherine Maclean. Medical marijuana and workers' compensation claiming. Health Economics (2020).",
        "Gittell, Ross, Jon D. Samuels, and Edinaldo Tebaldi. The Contribution of Associate's Degree Holders to US Earnings, Labor Quality, Productivity, and Overall Economic Growth. Southern Economic Journal 84, no. 2 (2017): 600-636.",
        "Goodnough, Abby and Katie Zezima. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Drug is harder to abuse, but users persevere.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d New York Times, June 15, 2011.",
        "Gresenz, Carole Roan, Katherine Watkins, and Deborah Podus. Supplemental security income (SSI), disability insurance (DI), and substance abusers. Community Mental Health Journal 34, no. 4 (1998): 337-350.",
        "Harris, Matthew C., Lawrence M. Kessler, Matthew N. Murray, and Beth Glenn. Prescription Opioids and Labor Market Pains: The Effect of Schedule II Opioids on Labor Force Participation and Unemployment. Journal of Human Resources (2019): 1017-9093R2.",
        "Jiang, Ruixuan, Inyoung Lee, Todd A. Lee, and A. Simon Pickard. The societal cost of heroin use disorder in the United States. PloS one 12, no. 5 (2017): e0177323.",
        "Kaestner, Robert. The Effect of Illicit Drug Use on the Labor Supply of Young Adults. Journal of Human Resources (1994): 126-155.",
        "Kahn-Lang, Ariella, and Kevin Lang. The Promise and Pitfalls of Differences-in-Differences: Reflections on 16 and Pregnant and Other Applications. Journal of Business & Economic Statistics (2019): 1-14.",
        "Kilby, Angela. Opioids for the masses: welfare tradeoffs in the regulation of narcotic pain medications. Cambridge: Massachusetts Institute of Technology (2015).",
        "Kolodny, Andrew, David T. Courtwright, Catherine S. Hwang, Peter Kreiner, John L. Eadie, Thomas W. Clark, and G. Caleb Alexander. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annual Review of Public Health 36 (2015): 559-574.",
        "Krueger, Alan B. Where have all the workers gone? An inquiry into the decline of the US labor force participation rate. Brookings Papers on Economic Activity 2017, no. 2 (2017): 1.",
        "Liebman, Jeffrey B. Understanding the increase in disability insurance benefit receipt in the United States. Journal of Economic Perspectives 29, no. 2 (2015): 123-50.",
        "MacDonald, Ziggy, and Stephen Pudney. Illicit drug use, unemployment, and occupational attainment. Journal of Health Economics 19, no. 6 (2000): 1089-1115.",
        "Maclean, Johanna Catherine, Keshar M. Ghimire, and Lauren Hersch Nicholas. Medical marijuana laws and disability applications, receipts, and terminations. National Bureau of Economic Research Working Paper No. 23862 (2019).",
        "Maestas, Nicole, Kathleen J. Mullen, and David Powell. The effect of population aging on economic growth, the labor force and productivity. No. w22452. National Bureau of Economic Research, 2016.",
        "Maestas, Nicole, Kathleen J. Mullen, and Alexander Strand. Does disability insurance receipt discourage work? Using examiner assignment to estimate causal effects of SSDI receipt. American Economic Review 103, no. 5 (2013): 1797-1829.",
        "Maestas, Nicole, Kathleen J. Mullen, and Alexander Strand. The effect of economic conditions on the disability insurance program: Evidence from the Great Recession. No. w25338. National Bureau of Economic Research, 2018.",
        "McCully, Clinton P. Integration of Micro-and Macrodata on Consumer Income and Expenditures. In Measuring Economic Sustainability and Progress, pp. 137-179. University of Chicago Press, 2014.",
        "Moore, Timothy J. The employment effects of terminating disability benefits. Journal of Public Economics 124 (2015): 30-43.",
        "Mueller, Andreas I., Jesse Rothstein, and Till M. Von Wachter. Unemployment insurance and disability insurance in the Great Recession. Journal of Labor Economics 34, no. S1 (2016): S445-S475.",
        "Nicholas, Lauren Hersch, and Johanna Catherine Maclean. The effect of medical marijuana laws on the health and labor supply of older adults: Evidence from the Health and Retirement Study. Journal of Policy Analysis and Management 38, no. 2 (2019): 455-480.",
        "Noblitt, Randy, and Pamela Noblitt. Social Security disability criteria and substance dependence. Professional Psychology: Research and Practice 43, no. 2 (2012): 94.",
        "Pardo, Bryce, Jonathan P. Caulkins, Beau Kilmer, Rosalie Liccardo Pacula, Peter Reuter, and Bradley D. Stein. The Synthetic Opioid Surge in the United States. (2019).",
        "https://www.rand.org/pubs/research_reports/RR3116.html Powell, David, Abby Alpert, and Rosalie L. Pacula. A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis C. Health Affairs 38, no. 2 (2019): 287-294.",
        "Powell, David, Rosalie Liccardo Pacula, and Mireille Jacobson. Do medical marijuana laws reduce addictions and deaths related to pain killers? Journal of Health Economics 58 (2018): 29-42. Powell, David and Rosalie Liccardo Pacula. \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093The evolving consequences of OxyContin reformulation on drug overdoses.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d American Journal of Health Economics, forthcoming.",
        "Ruhm, Christopher J. Corrected US opioid\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u0090involved drug poisoning deaths and mortality rates, 1999\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2015. Addiction 113, no. 7 (2018): 1339-1344.",
        "Sabia, Joseph J., and Thanh Tam Nguyen. The effect of medical marijuana laws on labor market outcomes. The Journal of Law and Economics 61, no. 3 (2018): 361-396.",
        "Santos Silva, JMC, and Silvana Tenreyro. The log of gravity. The Review of Economics and Statistics 88, no. 4 (2006): 641-658.",
        "Savych, Bogdan, David Neumark, and Randall Lea. Do opioids help injured workers recover and get back to work? The impact of opioid prescriptions on duration of temporary disability. Industrial Relations: A Journal of Economy and Society 58, no. 4 (2019): 549-590.",
        "Schnell, Molly. Physician behavior in the presence of a secondary market: The case of prescription opioids. Mimeo, University of Princeton, 2017.",
        "Scholl, Lawrence, Puja Seth, Mbabazi Kariisa, Nana Wilson, and Grant Baldwin. Drug and opioidinvolved overdose deaths\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dUnited States, 2013\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2017. Morbidity and Mortality Weekly Report 67, no. 5152 (2019): 1419.",
        "Van Zee, Art. The promotion and marketing of OxyContin: commercial triumph, public health tragedy. American Journal of Public Health 99, no. 2 (2009): 221-227.",
        "Williams, Jenny, Rosalie Liccardo Pacula, and Rosanna Smart. De Facto or De Jure? Ethnic Differences in Quit Responses to Legal Protections of Medical Marijuana Dispensaries. No. w25555. National Bureau of Economic Research, 2019.",
        "Zarkin, Gary A., Thomas A. Mroz, Jeremy W. Bray, and Michael T. French. The relationship between drug use and labor supply for young men. Labour Economics 5, no. 4 (1998): 385-409."
    ]
}